Heparin Sodium injectable bags recalled due to potential sterility assurance issues
Pfizer is recalling 62,088 bags of Heparin Sodium injection nationwide due to potential bag leakage that could compromise sterility. No illnesses have been reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II drug recall for Heparin Sodium with theoretical risk of sterility compromise due to potential bag leakage. Per the severity rubric, this qualifies as a risk-of-harm product where injury has not yet been reported, resulting in High severity.
Plain-English summary
Pfizer Inc. is recalling Heparin Sodium 2,000 USP Units per 1,000 mL in 0.9% Sodium Chloride Injection due to a lack of assurance of sterility. The bags have the potential to leak, which could compromise the sterility of the medication.
Approximately 62,088 bags of Lot 5935283 (expires 12/01/2023) were distributed nationwide in the USA.
No illnesses or injuries have been reported to date. Patients and healthcare providers who have received or used this product should contact Pfizer or their healthcare provider if they have questions. Healthcare facilities should identify and quarantine any remaining stock from the affected lot.
This is a Class II drug recall issued by the FDA.
The recalled product
- Product
- HEPARIN SODIUM (HEPARIN SODIUM)
- Brand
- HEPARIN SODIUM
- Manufacturer
- Pfizer Inc.
- Category
- Drug — Injectable
- Hazard
- Affected units
- 62,088
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 5935283
- Exp. 12/01/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · HEPARIN SODIUM
- ModerateHeparin Sodium Injection Recalled Due to Labeling Issue
FDA (Drugs) · 2023-03-15
- SevereHospira Recalls Heparin Sodium Injection Due to Human Hair Particulate
FDA (Drugs) · 2014-12-31
- SevereFresenius Kabi Recalls Heparin Sodium Injection Due to Subpotency
FDA (Drugs) · 2014-03-12
- SevereHospira Recalls Heparin Sodium Bags Due to Sterility Concerns
FDA (Drugs) · 2014-02-05
Same manufacturer · Pfizer Inc.
See all →- HighEpinephrine injection vials recalled for lack of assurance of sterility
FDA (Drugs) · 2025-08-27
- HighSodium bicarbonate injection vials recalled for lack of assurance of sterility
FDA (Drugs) · 2025-08-27
- HighBicillin L-A penicillin vials recalled after particulates found during visual inspection
FDA (Drugs) · 2025-08-06
- HighBicillin L-A 2.4 million unit vials recalled after particulates found
FDA (Drugs) · 2025-08-06
- ModerateDobutamine Injection Recall Due to Discoloration and Cracked Vials
FDA (Drugs) · 2025-07-02
Same hazard · leakage
See all →- HighConvaTec Esteem Body Soft Convex Urostomy Pouches Recalled for Leakage
FDA (Devices) · 2026-08-26
- SevereStryker AHTO Tube Set Packaging Recalled for Handpiece Leaking
FDA (Devices) · 2026-08-12
- SevereMedtronic Perfusion Systems Recalls EOPA Elongated One-Piece Arterial Cannula Model 77522
FDA (Devices) · 2026-08-05
- HighICU Medical Recalls Hotline Fluid Warming Sets Due to Leakage Risk
FDA (Devices) · 2026-07-29
- SevereABIOMED Introducer Kit 23 Fr heart pump accessory leakage risk
FDA (Devices) · 2026-07-22